Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Karlowsky

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|March 21, 2001
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisD F Sahm, J A Karlowsky, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillanceD F Sahm, I A Critchley, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamasesP R S Lagacé-Wiens, F Tailor, P Simner, et al.
Diagnostic Microbiology and Infectious Disease|November 25, 2023
Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021)A Walkty, J A Karlowsky, P R S Lagacé-Wiens, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida speciesJ A Karlowsky, G A Harding, S A Zelenitsky, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolonesG G Zhanel, J A Karlowsky, M H Saunders, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus speciesG G Zhanel, J A Karlowsky, G A Harding, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfareM E Jones, J Goguen, I A Critchley, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2002
In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and EuropeI A Critchley, M E Jones, P D Heinze, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000I A Critchley, R Blosser-Middleton, M E Jones, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|March 21, 2001
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisD F Sahm, J A Karlowsky, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillanceD F Sahm, I A Critchley, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamasesP R S Lagacé-Wiens, F Tailor, P Simner, et al.
Diagnostic Microbiology and Infectious Disease|November 25, 2023
Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021)A Walkty, J A Karlowsky, P R S Lagacé-Wiens, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida speciesJ A Karlowsky, G A Harding, S A Zelenitsky, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolonesG G Zhanel, J A Karlowsky, M H Saunders, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus speciesG G Zhanel, J A Karlowsky, G A Harding, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfareM E Jones, J Goguen, I A Critchley, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2002
In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and EuropeI A Critchley, M E Jones, P D Heinze, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000I A Critchley, R Blosser-Middleton, M E Jones, et al.
Pageof 8